Impact Therapeutics Announces Completion of Series D1 Financing

Corporate Breaking News

Home : Impact Therapeutics Announces Completion of Series D1 Financing

Mar 14 2022	Impact Therapeutics Announces Completion of Series D1 Financing
SHANGHAI, March 14, 2022 /PRNewswire/ -- IMPACT Therapeutics, a biopharmaceutical company dedicated to the discovery and development of targeted anti-cancer therapeutics based on synthetic lethality, announced the successful completion of its Series D1 financing. Institutional investors...


Source:https://www.prnewswire.com:443/news-releases/impact-therapeutics-announces-completion-of-series-d1-financing-301501583.html

Related News
» Azentio Software successfully delivered its Shariah-compliant profit calculation and distribution system for Bank of Abyssinia's Islamic window operations in record time » East Ventures becomes Indonesia's first venture capital firm to sign UN Principles for Responsible Investment